We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Single Probe Lithotriptor Facilitates Urological Procedures

By HospiMedica International staff writers
Posted on 05 Jul 2015
A next generation dual action lithotripsy system with integrated suction removes kidney stones even more efficiently.

The Olympus ShockPulse-SE (Stone Eliminator) lithotriptor integrates ultrasound and mechanical energies simultaneously from a single probe, thus enabling rapid fragmentation of all types of stones with minimal damage to surrounding tissue. More...
Stone management procedures are faster and more efficient due to superior drilling speed, intuitive single-handed control, and fragment aspiration via the large lumen of the device, reducing the time previously required capturing stones with graspers or baskets. The system comes with a full range of probes and sizes.

The single probe delivers constant ultrasonic wave energy with intermittent ballistic shockwave energy at a rate of 300 Hz. Reduced heat development during use avoids damaging surrounding tissues. Thanks to the single handpiece design, there is no need to connect separate pneumatic and ultrasonic transducers, and there is no need for a footswitch. The ergonomic placement of buttons allows for physician control during percutaneous nephrolithotomy (PCNL), ureterorenoscopy (URS), and bladder procedures. The Olympus ShockPulse-SE is a product of Olympus (Tokyo, Japan).

“This is an exciting time to be a medical device company in the urology space,” said Richard Reynolds, executive vice president of sales, marketing, and shared services at Olympus Corporation of the Americas Medical Systems Group. “New advancements in imaging, stone management, and the use of proprietary tumor detection technology, combined with our commitment to valuable partnerships and innovations in pricing structures, are helping physicians meet the triple aim of healthcare reform by improving quality, reducing costs, and enhancing patient satisfaction.”

Related Links:

Olympus



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Pulmonary Ventilator
OXYMAG
Silver Member
ECG Management System
NEMS Web
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.